Email Updates

Search form

You are here

27 MARCH 2015 VOLUME 16 ISSUE 13

Media Coverage

  • Research findings disseminated to district leaders at Bugiri Hospital by Community Participation for Improved Service Delivery (COPISED), a non-government organisation, revealed that Namayingo District had the highest HIV prevalence at 10 per cent, while Kaliro and Buyende districts had the lowest prevalence at 0.2 per cent and 0.1 per cent respectively....The major question one would ask from the COPISE report is what could explain the disparity in HIV infection among the different districts in Busoga.

    March 26, 2015
    Daily Monitor
  • The Conference on Retroviruses and Opportunistic Infections has recently taken place. At that event the UK PROUD (PRe-exposure Option for reducing HIV in the UK: immediate or Deferred) study of pre-exposure prophylaxis (PrEP) for MSM reported its results, prior to publication in the coming months. The headline figure is an astonishing 86% for the reduction of risk of infection in the intervention group....The good result achieved here is no doubt attributable to good adherence. It demonstrates, as these earlier trials have not, the true effectiveness of PrEP.

    March 26, 2015
    BMJ Blog
  • AIDS Project Los Angeles and APLA Health & Wellness are excited to announce that Vallerie Wagner, APLAHW’s chief operating officer, will receive the Advocate Award from Better Brothers LA in association with the DIVA Foundation. These organizations are recognizing Wagner for her extraordinary efforts to establish HIV/AIDS prevention and education initiatives in communities of color and for providing invaluable resources to communities disproportionately affected by HIV/AIDS.

    March 26, 2015
    Los Angeles Sentinel
  • First lady Jeannette Kagame has reaffirmed Rwanda's commitment to the fight HIV/AIDS, saying the country is using a holistic approach through a combination of laws and policies, and pro-women and girls programmes. Mrs Kagame was speaking at a forum on Women and HIV/AIDS in Washington DC, US, convened on Tuesday by amfAR - the Foundation for AIDS research. Under the theme, "Fast-Tracking the Global Response to HIV/AIDS," the conference brought together members of the US congress, diplomats, policymakers, researchers, and people living with HIV/AIDS.

    March 26, 2015
    New Times
  • At least 15 percent of the 500,000 people living with HIV who are on antiretroviral treatment stopped taking the life-prolonging drugs. Director of HIV and AIDS Unit in the [health] ministry, Frank Chimbwandira, disclosed this in an interview yesterday when he commented on recent revelations that many districts across the country are reporting high rates of ART defaulters. An ART nurse at Chikwawa District Health Office said that...“Surprisingly, the majority of these are expectant mothers whom we put on Option B+ for Prevention of Mother to Child Transmission (PMTCT).”

    March 26, 2015
    BNL Times
  • Just over 30 years ago, an international group of scientists discovered the HIV virus. While much progress has been made since the early days of the epidemic (in terms of awareness, prevention, and treatment), HIV and AIDS remain a leading cause of death worldwide, and rank as the number one cause of death both in Africa and among women of reproductive age. A cure has yet to be found, though every so often headlines contain the word “hope.”
    March 26, 2015
    The Atlantic
  • ...I am the principal investigator for the P18 Cohort Study, an investigation of young men who have sex with men, whom we have been tracking since they turned 18....When we assessed these young men at the onset of the study, only half of our sample reported a recent sexual health screening, and only 16 percent reported a rectal screening in their lifetimes, yet all were sexually active....More recent data from of our cohort at ages 22 to 23 reveal equally troubling information.

    March 25, 2015
    Newsweek
  • The Global Fund has canceled $574 million in grants to Malawi for fighting AIDS and asked for a $6.4 million refund over allegations of financial mismanagement, the health minister said Wednesday. Jean Kalilani said the Global Fund asked for the refund after the ministry of health and the National AIDS Commission (NAC) allegedly bought vehicles that were not budgeted for....Rights activists early this year staged countrywide protests and petitioned the Global Fund to stop funding NAC.

    March 25, 2015
    News Daily
  • Faced with a growing HIV outbreak tied to intravenous drug use, Indiana Gov. Mike Pence said Wednesday he's considering a needle-exchange program as part of a public health emergency he's preparing to declare in a county that's at the epicenter of the cases. Pence, a Republican, said he opposes needle exchanges as part of drug-control policy but is listening to health officials to determine the best way to stop the outbreak in Scott County in southern Indiana.

    March 25, 2015
    Baltimore Sun
  • There is evidence of increasing interest in HIV treatment as prevention among people living with HIV in the UK, with the number of people starting treatment at high CD4 cell counts doubling over a five-year period, according to data presented at a Public Health England meeting this week....In 2008, 75% of the 57,752 adults with diagnosed HIV were taking therapy. By 2013, this had increased to 86% of the 77,702 people with diagnosed HIV.

    March 25, 2015
    aidsmap
  • The scale-up of antiretroviral therapy (ART) in Kenya is being undermined by high rates of treatment failure, investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes....“We have demonstrated high virologic treatment failure among Kenyan ART patients and shown that peer support enhances adherence to improve treatment outcome,” conclude the authors. They recommend that adherence support using trained HIV-positive volunteers should be expanded and use of ART regimens recommended by WHO.

    March 25, 2015
    aidsmap
  • The World Health Organization country representative in The Gambia, Dr Charles Sagoe-Moses, has said despite the progress made, TB continues to be a major public health concern and the African region has the highest TB and TB/HIV co-infection rates in the world. The emerging challenge of drug resistant TB (MDR-TB) is yet to be adequately addressed, he added.

    March 25, 2015
    The Point
  • A new report by The Foundation for AIDS Research...notes that while HIV infections have decreased among members of the Black community vulnerable to HIV (Black women; babies; and injection drug users), they continue to increase among Black gay and bisexual men....The report concludes that the US HIV/AIDS epidemic cannot be addressed effectively without reducing new HIV infections among African Americans or gay men.

    March 25, 2015
    Edge Providence
  • The news will no doubt be met with varying degrees of regret and derision by the gay community....But it should also be met with a sense of loss....By developing its characters outside the well-worn grooves of television's flamboyant sidekicks and catty provocateurs of the past, "Looking" was charting new ground. It was also broaching subjects relatively untouched by television before, such as the HIV prevention treatment PrEP, and in doing so placed HIV within its modern context more so than any other show on television.

    March 25, 2015
    Baltimore Sun
  • Ministers from the UK and Scottish governments have apologised and pledged extra funding after it emerged that more than 3,000 people were infected by hepatitis C and HIV via contaminated blood more than 30 years ago....There were shouts of “whitewash” as the report was presented at the National Museum of Scotland in Edinburgh, and several relatives burned a copy of the five-volume report outside the building.

    March 25, 2015
    Guardian
  • Two meetings decades ago fundamentally changed AIDS treatment for the better. Will Vancouver 2015 be the meeting where science, rights and action get in sync and revolutionize the epidemic once again? Will Durban 2016 lead to massive mobilization for decisive action on ending the epidemic?

    March 25, 2015
    General
    Huffington Post
  • In the same way that the birth control pill revolutionized women’s sexual health, there’s a new pill to help prevent HIV infection that has the potential to do the same....PrEP....a once-day-a-pill. However, very few who could benefit from its use know about it—in particular, Black women. Given the disproportionate impact of the HIV epidemic on Black women, this lack of awareness of PrEP is troubling.

    March 25, 2015
    For Harriet
  • Many insurers offering health plans under the Affordable Care Act appear to have structured their drug formularies to dissuade high-cost patients — including those with HIV— from enrolling, according to...the New England Journal of Medicine....“Insurers have historically used tiered formularies to encourage enrollees to select generic or preferred brand-name drugs...,But if plans place all HIV drugs in the highest cost-sharing tier, enrollees with HIV will incur high costs regardless of which drugs they take.”

    March 25, 2015
    Healio
  • The Indiana Department of Health has asked CDC to help contain an outbreak of HIV in the southern part of the state that has resulted in 55 confirmed cases, up from 26 in February, with 13 more preliminary positive cases. Most who were infected had shared syringes while injecting oxymorphone hydrochloride. In addition to putting extra resources into getting people into drug treatment, the department has launched a public awareness campaign, "You Are Not Alone."

    March 24, 2015
    Pharmacist
  • Researchers at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA, presented data on several experimental agents that may play a role in achieving a 'functional cure' for HIV, or prolonged remission without disease progression. These include drugs that reactivate the latent HIV reservoir, interfere with expression of viral DNA and help the immune system target HIV-infected cells.

    March 24, 2015
    aidsmap
  • At least 200 women in Kabale district tested positive for cervical cancer, in a recent testing drive by Reproductive Health Uganda (RHU). Cervical cancer, or cancer of the cervix, mostly affects women above 25 years and those with HIV. It is a silent killer in Uganda because people don't want to test, finding out when it is too late...."It is common in women with HIV/AIDS because of their low immunity," RHU's Programme Coordinator, Annet Kyalimpa, said.

    March 24, 2015
    Observer
  • This week, the Centers for Disease Control and Prevention published two reports presenting the HIV prevalence and risk behaviors data related to HIV transmission and prevention among people who inject drugs (PWID). The data are from the 2012 cycle of the National HIV Behavioral Surveillance (NHBS) system. In total, 10,117 PWID were interviewed, of those, 10,002 were tested....The findings suggest that an integration of multiple service programs for PWID might increase the effectiveness of HIV prevention efforts.

    March 24, 2015
    The Body
  • A row over a law banning homosexuality in Uganda has been reignited after it emerged that the government paid a US public relations firm to offset negative publicity. Uganda's Observer newspaper said the government had spent 614 million shillings "to prop up Uganda's image" after it was "tarnished by the Anti-Homosexuality Act". It said that many MPs in the east African nation's parliament...were now refusing to approve the government's payment to Scribe Strategies and Advisors, a Washington-based lobbying firm.

    March 24, 2015
    Yahoo News
  • A blood thinning agent is helping researchers at the University of East Anglia understand more about the body's natural barriers to HIV. New research reveals how the protein langerin, which is present in genital mucous and acts as a natural HIV barrier during the first stages of contamination, interacts with the drug heparin. The research team has been able to identify two different mechanisms for that interaction -- involving different sites or 'faces' at the surface of the langerin protein.

    March 23, 2015
    Science Daily
  • Officially opening a two-day seminar in Selebi Phikwe on March 18, the United States ambassador, Mr Earl Miller, said over the 12 years the two governments had been working together, the American investment in this joint effort so far totaled more than US$700 million....Over the decade, new HIV infections dropped by 71 percent [and] the mother-to-child transmission rate...from around 40 percent to nearly 2 percent.

    March 23, 2015
    Botswana Daily News
  • Good mental health was the only significant factor associated with optimal pill-taking among people taking ART for prevention of sexual transmission of HIV, investigators from the HPTN 052 study report in the Journal of Acquired Immune Deficiency Syndromes.. High levels of adherence were observed after one month and one year of follow-up, and – unsurprisingly – people who took 95% of more of their ART doses were more likely to achieve virological suppression.

    March 23, 2015
    aidsmap
  • A group of experts from the World Health Organization (WHO) will arrive in Havana on Sunday, Mar. 22 to analyze the possible validation of Cuba as the first country in the world to eliminate syphilis and HIV/AIDS from mother to infant, or congenital transmission, according to UN health officials (computer translated). A team of at least 15 will visit doctor´s offices in neighborhoods in Havana, central Villa Clara and eastern Santiago de Cuba provinces, where they will evaluate the results of the Cuban Prevention Program for Sexually Transmitted Diseases.

    March 21, 2015
    Outbreak News Today
  • A Canadian paper that weighs the cost of using PrEP to prevent HIV infections against the lifetime total cost of one HIV infection finds that...PrEP would be cost-saving under most scenarios, even if the overall lifetime cost of HIV care falls in the future....Clearly, PrEP has considerable start-up costs and will not start saving money for health systems over the short term....However, given the results of the new studies, it is becoming hard to devise scenarios in which Truvada-based PrEP does not produce cost-savings in the long run.

    March 20, 2015
    aidsmap
  • There have been no new Ebola infections in Liberia in the past three weeks, but it's still far too early to say the virus has been defeated....But when the day does come and the crisis is declared over, how can prevention lessons be made to stick? Are there models to emulate from the global HIV campaign?...Both the HIV and Ebola public health campaigns have had to make the complex science of infection and disease control accessible, tackle stigma and counter rumour and misinformation.

    March 20, 2015
    IRIN
  • Atlanta is ranked No. 5 among US cities when it comes to the rate of new diagnoses of HIV. Experts say that's because routine HIV testing is not offered in the places where most people get their health care. By the time patients are diagnosed in Atlanta, almost one-third have advanced to clinical AIDS. Since starting a routine testing program in 2013, Grady Hospital has diagnosed an average of two or three patients with HIV every single day.

    March 20, 2015
    WABE/NPR
  • Since HIV emerged in the '80s, drug "cocktails" transformed the deadly disease into a manageable one. But the virus is adept at developing resistance to drugs, and treatment regimens require tweaking that can be costly. Now scientists at the 249th National Meeting & Exposition of the American Chemical Society (ACS) are announcing new progress toward affordable drugs that could potentially thwart the virus's ability to resist them.

    March 19, 2015
    Science Daily
  • By turning their backs on years of research work on fighting herpes viruses, Howard Hughes Medical Institute investigators at Albert Einstein College of Medicine say they were able to design a radically different type of vaccine that proved effective in mice. And they say the same vector has promise in fighting diseases like HIV and tuberculosis...."It was necessary to shake the field up and go another route," says Betsy Herold, a virologist and infectious disease physician at the Albert Einstein College of Medicine and co-study leader of the new research.

    March 10, 2015
    Fierce Biotech Research

Published Research

Announcements